A Method to Redesign and Simplify Schedules of Assessment and Quantify the Impacts. Applications to Merck Protocols

Abstract excerpt

The growing complexity of biopharmaceutical sponsored trials has adverse impacts on increased burdens on participants, clinical sites, and sponsors, including greater difficulty recruiting and retaining participants, difficulty engaging sites to participate in trials, excessive cost of trials, and increased cycle times. The schedule of assessments (SoAs) is the origin of and blueprint for complexity that is often...

Topics

Open a Topic to create a Post that cites this publication.

• Aniline Compounds
• Carcinoma, Non-Small-Cell Lung
• Lung Neoplasms
• Mutation
• Protein Kinase Inhibitors

Identifiers and source

Literature Corpus work

a7630800-5647-546c-8fc8-3cbfe7d1491d

DOI

10.1101/2024.01.02.24300749